Countless services have made our lives easier. One that has recently transformed lives and perceptions is Netflix.Netflix, a 'subscription' service where users can access content without ownership, swiftly inspired diverse subscription-based models. The global landscape now comfortably embraces paid
Pulmonary arterial hypertension (PAH) is a rare disease, in which blood pressure in the pulmonary arteries that supply blood from the heart to the lungs increases. About 1,500 Koreans are undergoing treatment, and the number of potential patients is estimated to reach 6,000.PAH's common symptoms inc
Recently, several cancer patients were admitted to university hospitals due to side effects after taking deworming medicines and one of them died, amid growing concerns over cancer patients’ rush to take anthelmintic drugs to cure their disease. A medical specialist’s YouTube video on how cancer patients should take fenbendazole, a dog dewormer, is increasingly causing controversy.
Korean Diabetes Association (KDA), Korea’s first healthcare-focused English online paper Korea Biomedical Review (KBR), and KBR’s sister paper The Korean Doctors’ Weekly agreed to work together to promote Korean medicine internationally.KDA, KBR, and The Korean Doctors’ Weekly signed a memorandum of understanding for global promotion of Korean medicine at KDA’s office in Seoul, on Wednesday.
The regulator said it would allow patients and guardians to check with information about clinical trials for participation quickly.The Ministry of Food and Drug Safety said it would open clinical trial information on the website at nedrug.mfds.go.kr on Saturday. Patients or guardians can find clinical trials information regarding diseases, hospital contacts, participation criteria, and progres
The Ministry of Food and Drug Safety said it would add 87 staff for the review of drug safety and efficacy next year to relieve the review overload and enhance its expertise regarding drug approval.Ministry officials said Thursday they had submitted to the National Assembly its plan to increase the number of reviewers of drugs and biopharmaceuticals by, 40 and reviewers of medical devices by 4
Allergan Korea CEO Kim Ji-hyun said she would lift the two-year time limit in providing breast implant replacements for people who used Allergan’s recalled products, which can cause rare cancer. The National Assembly’s Health and Welfare Committee conducted an audit of the Ministry of Food and Drug Safety on Monday and summoned Kim as a witness to ask her if the company’s compensation plan for
A civic group supporting diabetic patients said it would hold a rally to protest the regulator’s neglect of Medtronic’s insulin pumps, which the U.S. has recently recalled.The U.S. Food and Drug Administration ordered a recall of some Medtronic’s insulin pumps due to potential cybersecurity risks and listed the names of the products on its homepage in June.The FDA asked patients to check t
The Ministry of Food and Drug Safety is preparing to implement the “Act on Safety and Support for Advanced Regenerative Medicine and Advanced Biopharmaceuticals,” which takes effect on Aug. 27 next year. By the end of this year, the ministry aims to complete the draft of the enforcement decree and rules. As the law deals with R&D and safety management of advanced biopharmaceutical products suc
The Ministry of Food and Drug Safety said it might test all stomach medicines in the same class as ranitidine to check if they have an excessive level of N-Nitrosodimethylamine (NDMA), a potentially cancer-causing substance.“We are reviewing local and overseas materials whether to test ‘tidine-family’ drugs, besides ranitidine,” a ministry official told reporters on Tuesday.When the regula
Allergan agreed to provide full compensation for the medical expenses of patients who are diagnosed with implant-associated anaplastic large cell lymphoma (BIA-ALCL) after using Allergan’s textured implants.The Ministry of Food and Drug Safety said on Monday that the regulator and Allergan came up with a compensation plan for people who received the company’s textured implants.The compensa
The Ministry of Food and Drug Safety has suspended the sale of Novartis Korea’s Pataday 0.2 percent Eye Drops, a conjunctivitis treatment, until Dec. 22.The administrative penalty came after the regulator found that the company labeled the period of the use in the second packaging of Pataday (ingredient: olopatadine) differently from the authorized one.Pataday 0.2 percent Eye Drops tre
The Ministry of Food and Drug Safety has suspended the manufacturing and selling of 269 ranitidine-using medicines for heartburn, after detecting a carcinogen, N-Nitrosodimethylamine (NDMA).NDMA is an impurity designated by the World Health Organization's International Cancer Research Institute (IARC) as a potentially carcinogenic substance to humans, categorized in Group 2A. Last year, NDMA h
The government is likely to announce the results of the test on ranitidine heartburn drugs to see if they contained a carcinogen, N-Nitrosodimethylamine (NDMA), within a week or two.The Ministry of Food and Drug Safety is testing locally manufactured ranitidine raw materials for NDMA.Ministry officials said the testing was at the last stage and they could reveal the outcome this week,
India’s largest generics drugmaker Dr. Reddy's Laboratories said it would develop a biosimilar of Roche’s MabThera (ingredient: rituximab). The Indian company plans to conduct a phase-3 study on the biosimilar in Korea via clinical research service provider Parexel.The Ministry of Food and Drug Safety on Wednesday approved the phase-3 trial on DRL_RI, the biosimilar of rituximab.Rituximab
After U.S. health officials said they detected low levels of a potentially cancer-causing chemical N-Nitrosodimethylamine (NDMA) in popular heartburn treatments such as Zantac, the Ministry of Food and Drug Safety collected and inspected ranitidine-containing drugs on Sunday.“We are gathering and examining products in local distribution. We will take action when the results come out,” a minist
Lilly’s new migraine treatment Emgality Prefilled Pen Inj. (ingredient: galcanezumab) has won a local license. The Ministry of Food and Drug Safety on Thursday approved Emgality, as sought by Lilly Korea. The treatment can be prescribed to prevent migraine in adults. Emgality is a Calcitonin Gene-related Peptide (CGRP)-targeted antibody drug. CGRP is a small protein released by the
The drug regulator designated isatuximab, a treatment for relapsed and refractory multiple myeloma, as an orphan drug, granting additional indications for rufinamide and elotuzumab. The Ministry of Food and Drug Safety named isatuximab as a new orphan drug on Monday, under regulations for the designation of orphan drugs. Isatuximab received the orphan drug designation as “combi
Sunosi (ingredient: solriamfetol), a treatment for narcolepsy developed by SK Biopharmaceutical and licensed-out to Jazz Pharmaceuticals, had been a failure, an executive at SK Biopharmaceutical said.Park Jung-shin, vice president of SK Biopharmaceutical for clinical research, shared the story behind the development of Sunosi when she spoke on a non-clinical trial strategy in central nervous s
Fear is spreading among Korean women who received Allergan’s specific breast implant after news reports said those who used the company’s BIOCELL product were more likely to develop breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), rare cancer.The users of the product are particularly questioning whether the local regulator promptly responded to the problem, especially after